2040年的老年瘤学:探索潜在的现实和挑战. 一个多元化的视角
Raymond Gardner1, Luciola Pontes Leite de Barros2, Kwok Leung Cheung3
1The Royal Marsden NHS Foundation Trust, London, UK.
Journal of geriatric oncology
|February 27, 2026
概括
全球预期寿命正在上升,老年人癌症的增加. 本文综合了老年瘤学的挑战和机遇,重点关注未来十年的创新,公平和以患者为中心的护理.
科学领域:
- 老年瘤学 老年瘤学
- 公共卫生 公共卫生
- 医疗保健创新 医疗保健创新
背景情况:
- 预计到2040年,全球预期寿命将达到80岁,导致癌症的患病率增加,癌症是一种与衰老相关的疾病.
- 越来越多的癌症老年人群需要在服务提供,多学科合作和以患者为中心的护理方面取得进展.
研究的目的:
- 探索癌症老龄化人口的现实和挑战.
- 为决策者,医疗保健领导者,临床医生和患者提供战略资源,以应对老年瘤学的人口变化和技术进步.
- 促进老年人癌症护理中的公平,创新,质量和弹性.
主要方法:
- 对人口统计变化,技术进步和不断变化的患者需求进行多维透镜分析.
- 关于老年瘤学即将面临的挑战的专家观点的综合.
- 确定关键领域,包括精准医学,数字健康,医疗保健提供模式,劳动力培训和资源分配.
主要成果:
- 预计在癌症老年人护理方面会有更多的差异.
- 强调个性化干预和提高生活质量的重要性.
- 强调需要适应的医疗保健提供模式和劳动力培训.
结论:
- 战略规划对于应对全球人口老龄化中癌症负担不断增加至关重要.
- 精准医学,数字健康和以患者为中心的方法方面的创新是必不可少的.
- 利益相关者之间的合作至关重要,以确保未来的公平和有弹性的老年瘤护理.
相关概念视频
Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
302
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
302
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
765
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
765
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
288
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288
